A mathematical model for the treatment of prostate cancer regarding androgen ablation is considered. The effect of the therapy on healthy cells is taken into account and modelled as a second order state constraint. A mathematical overview about possible therapy strategies is presented. © 2020 ASSA
dynamics of prostate cancer patients treated with intermittent androgen suppressio
A mathematical model for time development of metastases and their distribution in size and carrying ...
Quantitative mathematical modeling of PSA dynamics of prostate cancer patients treated with intermit...
Predicting the timing of a castrate resistant prostate cancer is critical to lowering medical costs ...
AbstractConsiderable research is aimed at determining the mechanisms by which hormone-refractory pro...
Abstract: We propose a method for achieving an optimal protocol of intermittent androgen suppression...
In metastatic castrate resistant prostate cancer (mCRPC), abiraterone is conventionally administered...
Prostate cancer is a hormone-dependent cancer characterized by two types of cancer cells, androgen-d...
Chemotherapy is a common treatment for advanced prostate cancer. The standard approach relies on cyt...
Intermittent androgen deprivation therapy is often used to treat prostate cancer, but there are few ...
Considerable research is aimed at determining the mechanisms by which hormone-refractory prostate ca...
In the absence of curative therapies, treatment of metastatic castrate-resistant prostate cancer (mC...
Previous studies on prostate cancer modeling under hormonal therapy successfully fit clinical serum ...
Prostate cancer is the most common malignancy in males and, despite a marked improvement in diagnost...
International audienceDespite significant advances in oncological research, cancer nowadays remains ...
dynamics of prostate cancer patients treated with intermittent androgen suppressio
A mathematical model for time development of metastases and their distribution in size and carrying ...
Quantitative mathematical modeling of PSA dynamics of prostate cancer patients treated with intermit...
Predicting the timing of a castrate resistant prostate cancer is critical to lowering medical costs ...
AbstractConsiderable research is aimed at determining the mechanisms by which hormone-refractory pro...
Abstract: We propose a method for achieving an optimal protocol of intermittent androgen suppression...
In metastatic castrate resistant prostate cancer (mCRPC), abiraterone is conventionally administered...
Prostate cancer is a hormone-dependent cancer characterized by two types of cancer cells, androgen-d...
Chemotherapy is a common treatment for advanced prostate cancer. The standard approach relies on cyt...
Intermittent androgen deprivation therapy is often used to treat prostate cancer, but there are few ...
Considerable research is aimed at determining the mechanisms by which hormone-refractory prostate ca...
In the absence of curative therapies, treatment of metastatic castrate-resistant prostate cancer (mC...
Previous studies on prostate cancer modeling under hormonal therapy successfully fit clinical serum ...
Prostate cancer is the most common malignancy in males and, despite a marked improvement in diagnost...
International audienceDespite significant advances in oncological research, cancer nowadays remains ...
dynamics of prostate cancer patients treated with intermittent androgen suppressio
A mathematical model for time development of metastases and their distribution in size and carrying ...
Quantitative mathematical modeling of PSA dynamics of prostate cancer patients treated with intermit...